FTC Sanctions Vs DoNotPay Miss The Bigger Problem
The FTC in the US has hit DoNotPay with a range of sanctions, including a $193,000 fine, for offering legal AI services to consumers, even …
Admin
7 Steps to Mastering Coding for Data Science
Want to learn coding for data science? This seven-step guide will help you in your learning journey.
Infodash Partners with BigHand for Better Business Intelligence
Infodash, a provider of legal intranet and extranet solutions for law firms, has partnered with BigHand to broaden their Business Intelligence solution. In terms of …
How to Create Interactive Visualizations in R
Interactive visualizations allow users to engage with data in a dynamic way. In this article, you’ll learn how to make interactive plots using R packages.
The AI Price War: How Lower Costs Are Making AI More Accessible
A decade ago, developing Artificial Intelligence (AI) was something only big companies and well-funded research institutions could afford. The necessary hardware, software, and data storage costs were very high. But…
Thor Olof Philogène, CEO & Founder of Stravito – Interview Series
Thor Olof Philogène is the CEO and Founder of Stravito, an award-winning Swedish SaaS Scale-up whose AI-powered enterprise insights platform allows the world’s largest companies to easily store, discover, and…
5 Networking Tasks that AI Can Help NetOps With, And 5 It Can’t
Today’s digital landscapes are evolving rapidly as the complexity and scale of network infrastructure continues to grow exponentially. This surge is making it more challenging than ever to manage networks…
Zenlytic Secures $9M to Revolutionize Business Intelligence with AI-Powered Data Analyst Zoë
Zenlytic, a trailblazer in AI-powered business intelligence (BI), has successfully raised $9 million in a Series A funding round led by M13, alongside participation from Bain Capital Ventures, Primary Ventures,…
Fundamentals of Effective Prompt Engineering
Learn the fundamentals of mastering the art and science of prompting.
AI-Driven Drug Discovery Achieves Milestone with Insilico Medicine’s Phase IIa Success in Treating Pulmonary Fibrosis
Insilico Medicine’s Generative AI-designed Drug ISM001-055 Shows Promising Results in Phase IIa Clinical Trials In a breakthrough for AI-powered drug discovery, Insilico Medicine announced positive Phase IIa results for its…